Provider
P18-20 Lab Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Program effective Date: Mar 02, 2020
Search Results
Displaying 2081 - 2090 of 4269 results
Provider
P17-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Program effective Date: Mar 02, 2020
Provider
QP23-20 Blue Cross Basic Seminar Now Available On-Demand through the Availity Portal
Program effective Date: Feb 26, 2020
Provider
QP17-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Wakix ®
Program effective Date: Feb 12, 2020
Provider
QP14R1-20 Update: New Service Type Options for Inpatient Admission Notifications on Availity Portal
Program effective Date: Feb 12, 2020
Provider
QP19-20 Provider Overpayments and Overpayment Recoupment for MHCP
Program effective Date: Feb 12, 2020
Provider
QP22-20 Pharmacy Benefit Exclusion for Tepezza TM
Program effective Date: Feb 12, 2020
Provider
QP16-20 Pharmacy Benefit Exclusion for Padcev TM and Enhertu ®
Program effective Date: Feb 12, 2020
Provider
QP21-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Baclofen
Program effective Date: Feb 12, 2020
Provider
QP18-20 Pharmacy Benefit Exclusion for Calcipotriene-Betamethasone Dipropionate Suspension 0.005-0.064% (authorized generic (AG) of Taclonex suspension)
Program effective Date: Feb 12, 2020